Evaluation of a pharmaceutical care model on diabetes management

OBJECTIVE: To assess the effectiveness of a pharmaceutical care model on the management of non-insulin-dependent diabetes mellitus (NIDDM) in urban African-American patients. DESIGN: Eligible patients were randomized to either a pharmacist intervention or control group and followed over a 4-month period. Patients in the intervention group received diabetes education, medication counseling, instructions on dietary regulation, exercise, and home blood glucose monitoring, and evaluation and adjustment of their hypoglycemic regimen. Patients in the control group continued to receive standard medical care provided by their physicians. SETTING: A university-affiliated internal medicine outpatient clinic. PARTICIPANTS: The study population consisted of urban African American patients with NIDDM currently attending the clinic. MAIN OUTCOME MEASURES: Primary outcome measures included fasting plasma glucose and glycated hemoglobin concentrations. Secondary outcome endpoints included blood pressure, serum creatinine, creatinine clearance, microalbumin to creatinine ratio, total cholesterol, triglycerides, high-density lipoprotein, and low density lipoprotein concentrations. Quality-of-life assessments were performed in both groups at baseline and at the end of the study. RESULTS: Thirty-nine patients (17 intervention, 22 control) completed the study. The intervention group consisted of 12 women and 5 men with a mean +/- SD age of 59 +/- 12 years, total body weight (TBW) of 93 +/- 22 kg, body mass index (BMI) of 34 +/- 7 kg/m2, and duration of NIDDM 6.8 +/- 6.5 years. The control group consisted of 15 women and 7 men with a mean age of 65 +/- 12 years, TBW of 88 +/- 19 kg, BMI of 33 + 7 kg/m2, and a duration of NIDDM of 6.2 +/- 4.8 y. Significant improvement in glycated hemoglobin (p = 0.003) and fasting plasma glucose (p =0.015) was achieved in the intervention group. No change in glycemia was observed in the control subjects. Statistically significant differences in the final glycated hemoglobin (p = 0.003) and fasting plasma glucose (p = 0.022) concentrations were noted between groups. No significant changes in blood pressure control, lipid profile, renal function parameters, weight, or quality-of-life measures were noted within or between groups. CONCLUSIONS: Our data demonstrate the effectiveness of pharmaceutical care in the reduction of hyperglycemia associated with NIDDM in a group of urban African-American patients.

This article has been cited by other articles:

				L. Shane-McWhorter, B. Armor, J. T. Johnson, N. Letassy, S. L. Reichert, E. M. Sisson, J. B. S. Hanson, C. Triplett, and E. M. Vivian Pharmacist Scope of Practice, Standards of Practice, and Standards of Professional Performance for Diabetes Educators The Diabetes Educator, November 1, 2009; 35(3_suppl): 69S - 84S. [Full Text] [PDF]

				E. I. Boutati and S. A. Raptis Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes Diabetes Care, November 1, 2009; 32(suppl_2): S205 - S210. [Abstract] [Full Text] [PDF]

				M. J O'Kane and J. Pickup Self-monitoring of blood glucose in diabetes: is it worth it? Ann Clin Biochem, July 1, 2009; 46(4): 273 - 282. [Abstract] [Full Text] [PDF]

				G. R Ellitt, J.-a. E Brien, P. Aslani, and T. F Chen Quality Patient Care and Pharmacists' Role in Its Continuity--A Systematic Review Ann. Pharmacother., April 1, 2009; 43(4): 677 - 691. [Abstract] [Full Text] [PDF]

				J. P. Anaya, J. O. Rivera, K. Lawson, J. Garcia, J. Luna Jr., and M. Ortiz Evaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement Am. J. Health Syst. Pharm., October 1, 2008; 65(19): 1841 - 1845. [Abstract] [Full Text] [PDF]

				M. Machado, J. Bajcar, G. C Guzzo, and T. R Einarson Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management Ann. Pharmacother., November 1, 2007; 41(11): 1770 - 1781. [Abstract] [Full Text] [PDF]

				N. Brooks and R. R. Prevost Pharmacy Review: Reducing the Risks of Diabetes: The Pharmacist's Perspective American Journal of Lifestyle Medicine, October 1, 2007; 1(5): 356 - 357. [Abstract] [PDF]

				M. Machado, J. Bajcar, G. C Guzzo, and T. R Einarson Sensitivity of Patient Outcomes to Pharmacist Interventions. Part I: Systematic Review and Meta-Analysis in Diabetes Management Ann. Pharmacother., October 1, 2007; 41(10): 1569 - 1582. [Abstract] [Full Text] [PDF]

				H. M. Krumholz, P. M. Currie, B. Riegel, C. O. Phillips, E. D. Peterson, R. Smith, C. W. Yancy, and D. P. Faxon A Taxonomy for Disease Management: A Scientific Statement From the American Heart Association Disease Management Taxonomy Writing Group Circulation, September 26, 2006; 114(13): 1432 - 1445. [Abstract] [Full Text] [PDF]

				K. G. Shojania, S. R. Ranji, K. M. McDonald, J. M. Grimshaw, V. Sundaram, R. J. Rushakoff, and D. K. Owens Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA, July 26, 2006; 296(4): 427 - 440. [Abstract] [Full Text] [PDF]

				J. Leeman Interventions to Improve Diabetes Self-management: Utility and Relevance for Practice. The Diabetes Educator, July 1, 2006; 32(4): 571 - 583. [Abstract] [Full Text] [PDF]

				C. D. Saudek, R. L. Derr, and R. R. Kalyani Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A1c JAMA, April 12, 2006; 295(14): 1688 - 1697. [Abstract] [Full Text] [PDF]

				T. M. Davis, R. M Clifford, W. A Davis, and K. T Batty The role of pharmaceutical care in diabetes management The British Journal of Diabetes & Vascular Disease, November 1, 2005; 5(6): 352 - 356. [Abstract] [PDF]

				J. Chodosh, S. C. Morton, W. Mojica, M. Maglione, M. J. Suttorp, L. Hilton, S. Rhodes, and P. Shekelle Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults Ann Intern Med, September 20, 2005; 143(6): 427 - 438. [Abstract] [Full Text] [PDF]

				P. Bray, M. Roupe, S. Young, J. Harrell, D. M. Cummings, and L. M. Whetstone Feasibility and Effectiveness of System Redesign for Diabetes Care Management in Rural Areas: The Eastern North Carolina Experience The Diabetes Educator, September 1, 2005; 31(5): 712 - 718. [Abstract] [Full Text] [PDF]

				R. M. Clifford, W. A. Davis, K. T. Batty, and T. M.E. Davis Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes: The Fremantle Diabetes Study Diabetes Care, April 1, 2005; 28(4): 771 - 776. [Abstract] [Full Text] [PDF]

				P. S Odegard, A. Goo, J. Hummel, K. L Williams, and S. L Gray Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention Ann. Pharmacother., March 1, 2005; 39(3): 433 - 440. [Abstract] [Full Text] [PDF]

				M. J Storimans, O. H Klungel, H. Talsma, and C. J de Blaey Geographic region influences pharmacy's dispensing of blood glucose test strips Ann. Pharmacother., October 1, 2004; 38(10): 1751 - 1752. [Full Text] [PDF]

				B. L Armor and M. L Britton Diabetes Mellitus Non-Glucose Monitoring: Point-of-Care Testing Ann. Pharmacother., June 1, 2004; 38(6): 1039 - 1047. [Abstract] [Full Text] [PDF]

				R. W Grant, N. G Devita, D. E Singer, and J. B Meigs Improving Adherence and Reducing Medication Discrepancies in Patients with Diabetes Ann. Pharmacother., July 1, 2003; 37(7): 962 - 969. [Abstract] [Full Text] [PDF]

				C. A. Sarkisian, A. F. Brown, K. C. Norris, R. L. Wintz, and C. M. Managione A Systematic Review of Diabetes Self-Care Interventions for Older, African American, or Latino Adults The Diabetes Educator, May 1, 2003; 29(3): 467 - 479. [Abstract] [PDF]

				S. R Weingarten, J. M Henning, E. Badamgarav, K. Knight, V. Hasselblad, A. Gano Jr, and J. J Ofman Interventions used in disease management programmes for patients with chronic illness---which ones work? Meta-analysis of published reports BMJ, October 26, 2002; 325(7370): 925 - 925. [Abstract] [Full Text] [PDF]

				C. D. Ponte The Pharmacistas Educator and Storyteller The Diabetes Educator, September 1, 2002; 28(5): 682 - 685. [PDF]

				S. N. Nowak, R. Singh, A. Clarke, E. Campbell, and L. A. Jaber Metabolic Control and Adherence to American Diabetes Association Practice Guidelines in a Pharmacist-Managed Diabetes Clinic Diabetes Care, August 1, 2002; 25(8): 1479 - 1479. [Full Text] [PDF]

				C. M. Renders, G. D. Valk, S. J. Griffin, E. H. Wagner, J. ThM. Eijk van, and W. J.J. Assendelft Interventions to Improve the Management of Diabetes in Primary Care, Outpatient, and Community Settings: A systematic review Diabetes Care, October 1, 2001; 24(10): 1821 - 1833. [Abstract] [Full Text] [PDF]

				D. W. Bates A 40-Year-Old Woman Who Noticed a Medication Error JAMA, June 27, 2001; 285(24): 3134 - 3140. [Full Text] [PDF]

				W. A. Gattis, V. Hasselblad, D. J. Whellan, and C. M. O'Connor Reduction in Heart Failure Events by the Addition of a Clinical Pharmacist to the Heart Failure Management Team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study Arch Intern Med, September 13, 1999; 159(16): 1939 - 1945. [Abstract] [Full Text] [PDF]